Ontology highlight
ABSTRACT:
SUBMITTER: Eberly AR
PROVIDER: S-EPMC8160280 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature
Eberly Allison R AR Germer Jeffery J JJ Boerger Aimee C AC Fernholz Emily C EC Binnicker Matthew J MJ Yao Joseph D JD
Diagnostic microbiology and infectious disease 20210528 2
To meet the testing demands and overcome supply chain issues during the SARS-CoV-2 pandemic, many clinical laboratories validated multiple SARS-CoV-2 molecular testing platforms. Here, we compare three different molecular assays for SARS-CoV-2 that received emergency use authorization (EUA) from the U.S. Food and Drug Administration. In order to determine the agreement among Roche cobas® SARS-CoV-2 Test (Cobas), Abbott RealTime SARS-CoV-2 assay (ART), and Mayo Clinic Laboratory SARS-CoV-2 Molecu ...[more]